SLRA Presentation & Dinner – June 2016

//SLRA Presentation & Dinner – June 2016

Loading Events
This event has passed.
Saint Louis University School of Medicine

St. Louis Rheumatology Association

Wednesday, June 16th, 2016

Vibeke Strand, MD, FACP, FACR

Vibeke Strand, MD, FACP, FACR

Update on the approval of biosimilars in the United States

Vibeke Strand, MD, FACP, FACR is the Adjunct Clinical Professor for the Division of Immunology/Rheumatology at Stanford University and a Biopharmaceutical Consultant.

Dr. Strand serves a consultant in clinical research and regulatory affairs to pharmaceutical and biotech companies. She graduated from Swarthmore College with honors, attended the University of California, San Francisco School of Medicine and returned there to complete her subspecialty Rheumatology Fellowship. She was one of eight in the first Primary Care Internal Medicine Residency at Michigan State University. She has been a clinical rheumatologist for 30 years – in subspecialty practice in San Francisco, as a clinical investigator, as an IRB member and subsequently as the director of clinical research at 3 pharmaceutical and biotech companies.

6:00 – 6:30 pm Registration

6:30 – 9:00 pm Presentation and dinner

Nieman Marcus, Zodiac Room, Hwy 40 and

Lindbergh

REGISTER FOR CME

This live activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Washington University School of Medicine, Continuing Medical Education and St. Louis Rheumatology Association.  Washington University is accredited by the ACCME to provide continuing medical education for physicians.  Washington University designates this live activity for a maximum of _1_ AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

It is the policy of Washington University School of Medicine, Continuing Medical Education, to ensure balance, independence, objectivity and scientific rigor in all its educational activities.  All planners, faculty and other persons who may influence content of this CME activity have disclosed all relevant financial relationships with commercial interests. All disclosures have been reported and are indicated with their presentations.  Any potential conflicts were addressed and resolved.

 All members of the CME department have nothing to disclose.  Speakers are also expected to openly disclose inclusion of discussion of any off-label, experimental, or investigational use of drugs or devices in their presentations. Presentations are expected to be based on evidence that is accepted within the profession of medicine as adequate justification for their indication in the care of patients.  All scientific research should conform to the generally accepted standards of experimental design, data collection and analysis.

These presentations are not an endorsement of any commercial interests. These presentations are the views and experiences of the presenters.  The presenters’ views do not represent the policy or position of Washington University School of Medicine.  Washington University School of Medicine, Continuing Medical Education, is the sponsor for CME credits.

St. Louis Rheumatology Association

June 16, 2016

“Update on the approval of biosimilars in the United States”

Vibeke Strand, MD, FACP, FACR

Vibeke Strand, MD, FACP, FACR

Adjunct Clinical Professor
Division of Immunology/Rheumatology
Stanford University
Biopharmaceutical Consultant
6:30 – 7:00 pm Registration
7:00 – 9:00 pm Presentation and dinner
Zodiac Restaurant (2nd floor Nieman Marcus)
1701 South Lindbergh Blvd, Saint Louis, MO 63131

CME

This live activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Washington University School of Medicine, Continuing Medical Education and St. Louis Rheumatology Association.  Washington University is accredited by the ACCME to provide continuing medical education for physicians.  Washington University designates this live activity for a maximum of _1_ AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
It is the policy of Washington University School of Medicine, Continuing Medical Education, to ensure balance, independence, objectivity and scientific rigor in all its educational activities.  All planners, faculty and other persons who may influence content of this CME activity have disclosed all relevant financial relationships with commercial interests. All disclosures have been reported and are indicated with their presentations.  Any potential conflicts were addressed and resolved.
 All members of the CME department have nothing to disclose.  Speakers are also expected to openly disclose inclusion of discussion of any off-label, experimental, or investigational use of drugs or devices in their presentations. Presentations are expected to be based on evidence that is accepted within the profession of medicine as adequate justification for their indication in the care of patients.  All scientific research should conform to the generally accepted standards of experimental design, data collection and analysis.
These presentations are not an endorsement of any commercial interests. These presentations are the views and experiences of the presenters.  The presenters’ views do not represent the policy or position of Washington University School of Medicine.  Washington University School of Medicine, Continuing Medical Education, is the sponsor for CME credits.